Skip to main navigation
  • Technology
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Contact
Nautilus Biotechnology
  • Technology
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Contact

SEC Filings

  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly and Annual Results
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR
Filing date Form Description View
Jun 17, 2022 4

Statement of changes in beneficial ownership of securities

0001062993-22-015188.pdf
0001062993-22-015188.rtf
0001062993-22-015188.xls
View HTML
Jun 17, 2022 4

Statement of changes in beneficial ownership of securities

0001062993-22-015186.pdf
0001062993-22-015186.rtf
0001062993-22-015186.xls
View HTML
Jun 16, 2022 8-K

Report of unscheduled material events or corporate event

0001808805-22-000059.pdf
0001808805-22-000059.rtf
0001808805-22-000059.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jun 16, 2022 424B3

Form of prospectus reflecting facts events constituting substantive change from last form

0001808805-22-000060.pdf
0001808805-22-000060.rtf
0001808805-22-000060.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000069.pdf
0001808805-22-000069.rtf
0001808805-22-000069.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000071.pdf
0001808805-22-000071.rtf
0001808805-22-000071.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000070.pdf
0001808805-22-000070.rtf
0001808805-22-000070.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000068.pdf
0001808805-22-000068.rtf
0001808805-22-000068.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000073.pdf
0001808805-22-000073.rtf
0001808805-22-000073.xls
View HTML
Jun 16, 2022 4

Statement of changes in beneficial ownership of securities

0001808805-22-000072.pdf
0001808805-22-000072.rtf
0001808805-22-000072.xls
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 144 results

Data provided by Kaleidoscope.

Sign-up for updates

Sign Up

Nautilus Biotechnology

 

 

Corporate Headquarters
2701 Eastlake Avenue East
Seattle, WA 98102

 

 

 

Research Headquarters
835 Industrial Road, Suite 200
San Carlos, CA 94070

Nautilus Biotechnology

 

linkedin      twitter

info@nautilus.bio
+1 (206) 333-2001

© 2022 Nautilus Biotechnology Inc.

Privacy Policy | Terms